Business, energy, technology, markets and global industry news from Business News Today

China

PharmaDeviceNews China
Representative image of topical plaque psoriasis treatment and China market expansion, illustrating LEO Pharma’s Enstilar approval as the company targets growth in the world’s largest psoriasis patient market.
Pharma & Biotech

LEO Pharma wins China approval for Enstilar, but can topical psoriasis leadership scale in the world’s biggest patient market?

LEO Pharma has won China approval for Enstilar in plaque psoriasis. Read what it means for competition, access, and dermatology growth.

Read More
Pharma & Biotech

Mazdutide shows weight loss efficacy in Chinese teens: Phase 1b results raise hopes for approval

Innovent Biologics has reported that mazdutide, its dual GLP-1 and glucagon receptor agonist, achieved statistically significant reductions in both body mass index and weight in Chinese adolescents with obesity during a 12-week Phase 1b clinical trial. The trial met its primary endpoint, demonstrated a favorable safety profile, and paves the way for a Phase 3

Read More